Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.25 -0.05 (-0.68%) Market Cap: 2.31 Bil Enterprise Value: 4.84 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

Amneal Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 07:15PM GMT
Release Date Price: €5.1 (-3.77%)
Chris Schott J.P. Morgan;Analyst

So good morning, everybody. I'm Chris Schott at JPMorgan. And it's my pleasure to be introducing Amneal today from the company. We have Chirag Patel, who is the Co-Founder and Co-CEO of the Company. I'm sure he's going to do a presentation, and we're going to jump into Q&A from there. So with that Happy New Year, and thanks for joining us today.

Chirag Patel
Amneal Pharmaceuticals Pty Ltd - President, Co-Chief Executive Officer

Thank you, Chris. Good afternoon. I guess it's still good morning, almost good afternoon. Great to see all of you, and thank you for coming today. I'm going to start with a bit of a history for Glu is new and new was founded in 2002 by my brother and me our humble beginning in Patterson, New Jersey with the our own whatever family savings we had. And today, we're proud to have built America's third-largest generics company, which we'd like to we recoin the term and add the injectables and biosimilars and call it affordable medicines. So 7,000 employees multiple plants, so very great American

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot